(3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]- 3,5-dihydrosy-6-heptane acid | CAS:147511-70-4

We serve (3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]- 3,5-dihydrosy-6-heptane acid CAS:147511-70-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
(3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]- 3,5-dihydrosy-6-heptane acid

Chemical Name:(3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]- 3,5-dihydrosy-6-heptane acid
CAS.NO:147511-70-4
Synonyms:
(R)-Butyl phenyl carbinol
pitavastatin (R)-1-phenylethylamine salt
1-phenyl-1-pentanol
(R)-1-Phenylpentanol
(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid (R)-1-phenylethylamine salt
(+)-1-Phenylpentanol
pitavastatin phenylethanamine salt
(R)-1-phenyl-1-pentanol
(R)-1-phenylpentan-1-ol
phenyl n-butyl carbinol
(+)-1-Phenylpentan-1-ol
(R)-1-phenylethanamine (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate
 
Molecular Formula: C33H35FN2O4
Molecular Weight: 542.64000
 
Physical and Chemical Properties:
Density: 0.691 g/cm3
Boiling point: 14.2ºC at 760 mmHg
Melting point: /
Flash point: /
Refractive index: /
 
Specification:
Appearance: White to off-white crystalline powder
Purity:≥98%
Residue on Ignition: 0.1%
Moisture Content: <0.5%
Impurity: total <1.0%
 
Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Pitavastatin calcium CAS:147526-32-7
Intermediates of Pitavastatin CAS:147511-69-1



Contact us for information like (3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]- 3,5-dihydrosy-6-heptane acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(R)-1-phenylethanamine (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(R)-1-phenylpentan-1-ol Use and application,pitavastatin phenylethanamine salt technical grade,usp/ep/jp grade.


Related News: The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.Ethyl (E)-3,5-dihydroxy-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-hept-6-enoate manufacturer Any South Korean citizen returning home who has been in Hubei Province within the past two weeks will be subject to 14 days of self-quarantine and monitoring, the government said.3-AMINO-5-FLUOROPYRIDINE supplier Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.3-Nitrophthalonitrile vendor This requires enterprises to have high R & D strength and strategic foresight, keep reserves projects, and seize the market after patents expire.Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.